Erin J Green-Trexler

Title: The Innovative Contributions of Erin J Green-Trexler

Introduction

Erin J Green-Trexler is a notable inventor based in Green Lane, Pennsylvania. He has made significant contributions to the field of vaccine development, particularly in formulating dengue virus vaccine compositions. With a total of two patents to his name, his work is paving the way for advancements in public health.

Latest Patents

Erin's latest patents focus on formulations of dengue virus vaccine compositions. The first patent describes formulations that include at least one live, attenuated dengue virus or live, attenuated chimeric flavivirus, along with a buffer, sugar, cellulose derivative, glycol or sugar alcohol, and optionally an alkali or alkaline salt and an amino acid. The second patent also emphasizes similar formulations, specifying a sugar concentration of at least 150 mg/ml, a carrier, and the optional inclusion of an alkali or alkaline salt and an amino acid.

Career Highlights

Erin J Green-Trexler is currently associated with Merck Sharp & Dohme Corporation, a leading company in the pharmaceutical industry. His work at Merck has allowed him to focus on innovative vaccine research and development, contributing to the fight against infectious diseases.

Collaborations

Throughout his career, Erin has collaborated with esteemed colleagues, including Michael S Ryan and Sherrie-Ann P Martin. These collaborations have fostered a productive environment for innovation and research in vaccine development.

Conclusion

Erin J Green-Trexler's contributions to vaccine formulations are vital in addressing public health challenges. His innovative work at Merck Sharp & Dohme Corporation exemplifies the impact of dedicated inventors in the field of medicine.